About 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile
2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile (PubChem CID 69340143) has the molecular formula C17H16BrN3
and a molecular weight of 342.24 g/mol. Its IUPAC name is 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile.
Analyze 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile?
The IUPAC name of 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile (CID 69340143) is 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile.
What is the SMILES notation for 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile?
The canonical SMILES for 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile is N#CC(c1ccc2c(c1)CCNCC2)c1ccc(Br)cn1.
What is the InChIKey of 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile?
The InChIKey is JHASCQABYFZXQO-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H16BrN3/c18-15-3-4-17(21-11-15)16(10-19)14-2-1-12-5-7-20-8-6-13(12)9-14/h1-4,9,11,16,20H,5-8H2.
What are the key properties of 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile?
2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile has a molecular weight of 342.24 g/mol, XLogP of 3.19, 2 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(5-bromo-2-pyridinyl)-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)acetonitrile is sourced from PubChem (CID 69340143), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).